Trial intelligence / Profile preview

G-CSF for Implantation Success in IVF

NCT03163862Phase 3Unknown

Sponsor
Istishari Arab Hospital
Start
Aug 2017
Primary completion
Jun 2018
Modality
Cytokines & Interferons
01

Overview

Phase 3, randomised, double-blind trial of filgrastim in infertility (3 arms), sponsored by Istishari Arab Hospital. Primary endpoint: Clinical pregnancy per women randomized at 4 weeks. Status: unknown.

02

Drugs

filgrastim
03

Conditions

infertility

Beyond the preview

Go deeper on NCT03163862.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03163862.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call